Differences

This shows you the differences between two versions of the page.

--- home:diseases:osteoarthritis [01.05.2019] – [Research] sallieq
+++ home:diseases:osteoarthritis [01.05.2019] – [Research] sallieq
@@ Line 54: / Line 54: @@
 Altogether, our data show that tetracyclines have no inhibitory potential on any proteoglycanolytic activities within mild or moderately affected human OA cartilage at therapeutic achievable plasma levels.    (({{pubmed>long:20069635}}))
-Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health.  (({{pubmed>long:25788417}}))
+Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health.  <blockquote>We detected CP in the plasma of healthy subjects and surprisingly found that CP was increased in both patients with eOA and eRA whereas anti-CCP antibodies were predominantly present in eRA. A 4-class diagnostic algorithm combining plasma/serum CP, anti-CCP antibody and hydroxyproline applied to a cohort gave specific and sensitive detection and discrimination of eOA, eRA, other non-RA inflammatory joint diseases and good skeletal health.(({{pubmed>long:25788417}}))</blockquote>
-{{tag>disease incomplete}}
+{{tag>disease }}
-<note>Dear MPKB Reader: You have arrived at one of the articles that has not yet completed the development and review process in the knowledge base. Some of the content here may be helpful, but please know that this page is not complete. There are about 400 articles in the KB, and this is one we are still working on. Thanks for your patience.</note>

home/diseases/osteoarthritis.txt · Last modified: 09.14.2022 by 127.0.0.1